| Regina Hagstrand Pt, Pllc | |
|
246 Riverview Rd, Rexford, NY 12148-1649 | |
| (518) 371-9572 | |
| (518) 373-2063 |
| Full Name | Regina Hagstrand Pt, Pllc |
|---|---|
| Type | Facility |
| Speciality | Physical Therapist |
| Location | 246 Riverview Rd, Rexford, New York |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548674393 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 004157 (New York) | Primary |
| Provider Name | Regina Hagstrand |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1457328056 PECOS PAC ID: 9133393119 Enrollment ID: I20111201000452 |
News Archive
Researchers at the University of Pennsylvania and Yale University have manipulated the internal, structural components of cells, creating a set of simulated cellular structures with novel mechanical properties, including one that acts like a red blood cell and another that mimics the soft, elastic behavior commonly found in novel synthetic materials called liquid crystal elastomers.
The Associated Press/BusinessWeek examines the Singapore-based company Rigel Technology's efforts to sell "state-of-the-art portable, fertilizer-making, toilets for as low as $30" in developing countries. "Experts estimate about 2.5 billion people lack functioning, hygienic toilets and instead excrete in the open, a habit that can contaminate water supplies and spread diseases such as E. coli bacteria and other viruses," the publication writes.
Cerus Corporation announced today that it has signed an agreement to acquire BioOne Corporation's commercialization rights for the INTERCEPT Blood System for platelets and plasma, subject to approval of the transaction by BioOne's shareholders. In 2004 and 2005, Cerus and its partner at the time, Baxter International, licensed the commercialization rights for INTERCEPT platelets and plasma to BioOne for an Asian territory, which included China, Japan, Taiwan, Singapore, Korea, Thailand and Vietnam.
The number one killer of HIV patients in resource-limited areas, including parts of Africa and India, is tuberculosis (TB), underscoring the need for optimal treatments and effective strategies to address this deadly co-infection. But TB is harder to detect in HIV-infected patients and diagnostic test results take time, so many healthcare providers prescribe multi-drug TB treatments as a precaution.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Regina Hagstrand Pt, Pllc 246 Riverview Rd, Rexford, NY 12148-1649 Ph: (518) 371-9572 | Regina Hagstrand Pt, Pllc 246 Riverview Rd, Rexford, NY 12148-1649 Ph: (518) 371-9572 |
News Archive
Researchers at the University of Pennsylvania and Yale University have manipulated the internal, structural components of cells, creating a set of simulated cellular structures with novel mechanical properties, including one that acts like a red blood cell and another that mimics the soft, elastic behavior commonly found in novel synthetic materials called liquid crystal elastomers.
The Associated Press/BusinessWeek examines the Singapore-based company Rigel Technology's efforts to sell "state-of-the-art portable, fertilizer-making, toilets for as low as $30" in developing countries. "Experts estimate about 2.5 billion people lack functioning, hygienic toilets and instead excrete in the open, a habit that can contaminate water supplies and spread diseases such as E. coli bacteria and other viruses," the publication writes.
Cerus Corporation announced today that it has signed an agreement to acquire BioOne Corporation's commercialization rights for the INTERCEPT Blood System for platelets and plasma, subject to approval of the transaction by BioOne's shareholders. In 2004 and 2005, Cerus and its partner at the time, Baxter International, licensed the commercialization rights for INTERCEPT platelets and plasma to BioOne for an Asian territory, which included China, Japan, Taiwan, Singapore, Korea, Thailand and Vietnam.
The number one killer of HIV patients in resource-limited areas, including parts of Africa and India, is tuberculosis (TB), underscoring the need for optimal treatments and effective strategies to address this deadly co-infection. But TB is harder to detect in HIV-infected patients and diagnostic test results take time, so many healthcare providers prescribe multi-drug TB treatments as a precaution.
› Verified 2 days ago
Mrs. Regina C Hagstrand, P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 246 Riverview Rd, Rexford, NY 12148 Phone: 518-371-9572 Fax: 518-373-2063 |